Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

15574-96-6

Pizotifen

15574-96-6
24650-42-8

Dimethoxy-2-phenylacetophenone-2,2

24650-42-8
444731-52-6

Pazopanib

444731-52-6
812-70-4

3-Perfluoroheptyl Propanoic Acid

812-70-4
137071-32-0

Pimecrolimus

137071-32-0
2806-15-7

Sodium Perfluoro-1-decanesulfonate

2806-15-7
69782-91-8

PCB 193

69782-91-8
8049-47-6

Pancreatin

8049-47-6
553-69-5

Phenyramidol

553-69-5
61869-08-7

Paroxetine

61869-08-7
13925-07-0

2-Ethyl-3,5(6)-dimethylpyrazine

13925-07-0
629-76-5

Pentadecanol-1

629-76-5
766-90-5

Propenylbenzene-1-cis

766-90-5
3886-69-9

R-1-phenylethanamine

3886-69-9
78246-49-8

Paroxetine HCl

78246-49-8
147511-69-1

Pitavastatin Calcium

147511-69-1
58-74-2

Papaverine

58-74-2
139755-87-6

Propoxyphenyl Homohydroxysildenafil

139755-87-6
30557-04-1

rac 1-Palmitoyl-3-chloropropanediol

30557-04-1
81131-70-6

Pravastatin sodium

81131-70-6